“Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01% Tazarotene 0.045% (HP TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 1, Jan. 2020, p. S9, https://skin.dermsquared.com/skin/article/view/822.